Alan Nurden: Genome-Wide Analyses Unravel the Genetic Architecture of Coagulation and Fibrinolysis
Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared a post on LinkedIn about a recent article by Maria Sabater-Lleal et al, published in JTH:
“This is a very complete review of a very important field, explaining how genome-wide analyses are unraveling the genetic architecture responsible for the levels of the main cellular and plasma factors that regulate coagulation and fibrinolysis.
The authors combine this with a brief look at global coagulation tests, all this in the context of how multiple gene variants influence venous and arterial thrombosis.
Step by step we are approaching the day when whole genome sequencing will become the norm and a prerequisite for personalized medicine.
In my own field of inherited platelet disorders and in particular Glanzmann thrombasthenia, the polygenic scores of gene variants either favoring or protecting from excessive and frequent mucocutaneous bleeding should help select patients most apt for gene therapy or to receive new generation long-term prophylaxis designed to upgrade fibrin formation at sites of bleeding.
For the latter, determining the therapy dose will be crucial in assuring safety.
This review is highly recommended for all in the coagulation and hemostasis fields.”
Title: Historical review: more than two decades understanding the genetic architecture of hemostasis and thrombosis
Authors: Maria Sabater-Lleal, Florian Thibord, Paul S de Vries, Jennifer Huffman, Alisa S Wolberg, Charles J Lowenstein, Alanna C Morrison, Andrew D Johnson, Nicholas L Smith
Read the Full Article on JTH
Other articles featuring Alan Nurden on Hemostasis Today.
-
Apr 30, 2026, 18:19Deva Nanda TK: A Practical Overview of Dural Sinuses and The Venous Drainage of the Brain
-
Apr 30, 2026, 18:08Amrit Kaur Kaler: The Hidden Genetic Drivers of Thrombosis
-
Apr 30, 2026, 18:06Alejandro González Veliz: The Most Dangerous Mistake After Getting a Stent
-
Apr 30, 2026, 18:03Carmen Ruiz: First Arterial Mechanical Thrombectomy in New Zealand Using the ARTIX System
-
Apr 30, 2026, 17:52Simon Senanu: von Willebrand Disease May Be Missed Despite Normal Tests
-
Apr 30, 2026, 17:20José Antonio García Erce: Why Healthy Older Adults Should Keep Donating Blood?
-
Apr 30, 2026, 17:13Paul Logan: Decoding the Words ‘He’s on blood thinners’
-
Apr 30, 2026, 17:01Jason Andrade: A Decade-Long Quest Proves Early Ablation Halves Persistent AF Burden
-
Apr 30, 2026, 16:56Oliver Maracic: Could Co-Targeting ALK with FAK/PYK2 Help Mitigate the High VTE Burden Seen in ALK with NSCLC